The state of New York sees first drop in opioid deaths since 2009
After years of rising opioid-related overdoses deaths among state residents, 2018 finally saw a drop, from 2,170 deaths in 2017, to 1,824 deaths – a 15.9 percent decrease.
Mental health & addiction
Japan records lowest suicide rate since statistics were first kept in 1978
2018 marks the ninth consecutive with a year-on-year decrease in suicides in Japan and the first time in 37 years for the total to fall below 21,000.
Malaysia will decriminalize drug possession for personal use
A representative from the Malaysian government said that decriminalization is a step toward a rational drug policy that puts science and public health before punishment and incarceration.
Illinois to legalize marijuana sales, expunge criminal records for pot crimes
State lawmakers gave final approval to the bill Friday and Gov. JB Pritzker said he will sign the measure, which make Illinois the first state to legalize marijuana sales via its legislature.
New Zealand ‘wellbeing’ budget focuses resources on vulnerable populations
New Zealand’s Labour coalition government has unveiled its “world-first” well-being budget which offers billions for mental health services, child poverty, and family violence.
Study finds CBD effective in treating heroin addiction
Given to patients with heroin addiction, cannabidiol, also known as CBD, reduced their cravings for the illicit drug as well as their levels of anxiety.
Denver voters approve decriminalizing “magic mushrooms”
Denver voters approved a measure to decriminalize psychedelic mushrooms. Psilocybin has been touted for treating a variety of psychological issues, including depression.
Mexico plans to legalize cannabis by October 2019
Mexican lawmakers will hash out the details of a marijuana regulation bill during the upcoming summer recess, with the goal of passing the legislation ahead of an October deadline, a key committee leader said.
New research suggests MDMA lets PTSD victims form new bonds and memories to overcome trauma
Research from Johns Hopkins University finds that MDMA seems to re-open a window of opportunity for social bonding and rewiring trauma-related faulty connections in the brain.
U.S. FDA approves first ever treatment for postpartum depression
The newly-approved drug, sold under the brand name Zulresso, was shown to relieve depressive symptoms within hours of being administered in three different clinical trials — and it continued to show success throughout their 30-day followups.